Nautilus Biotechnology (NAUT) Other financing activities (2020 - 2021)
Nautilus Biotechnology's (NAUT) quarterly Other financing activities came in at $47000.0 in Q3 2021, down 98.61% year-on-year from $3.4 million in Q3 2020, and down 99.22% quarter-over-quarter from $6.0 million in Q2 2021.
Nautilus Biotechnology (NAUT) Other financing activities (2020 - 2021) Analysis & Trends
Nautilus Biotechnology has disclosed Other financing activities across 2 years of filings, most recently posting $47000.0 for Q3 2021.
- Other financing activities for Q3 2021 came in at $47000.0, down 98.61% year-over-year; the trailing twelve-month figure through Jun 2022 was $47000.0 (down 99.68% YoY), and the FY2021 annual result was $8.1 million, changed N/A from the prior year.
- Other financing activities came in at $47000.0 for Q3 2021 at Nautilus Biotechnology, down from $6.0 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $6.0 million in Q2 2021 to a low of $47000.0 in Q3 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Nautilus Biotechnology | 289.99 Mn | 194.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 47,000.00 |
| Sep 30, 2021 | 47,000.00 |
| Jun 30, 2021 | 6.01 Mn |
| Jun 30, 2021 | 6.01 Mn |
| Mar 31, 2021 | 2.07 Mn |
| Mar 31, 2021 | 2.07 Mn |
| Dec 31, 2020 | 3.38 Mn |
| Dec 31, 2020 | 3.38 Mn |
| Sep 30, 2020 | 3.38 Mn |
| Sep 30, 2020 | 3.38 Mn |
| Jun 30, 2020 | 200,000.00 |
| Jun 30, 2020 | 200,000.00 |